Navigation Links
Abbott Donates Diagnostic Instruments As Part of the 'Labs Are Vital(TM)' Initiative

WASHINGTON, July 30 /PRNewswire-FirstCall/ -- Abbott today announced the recipients of the Labs Are Vital(TM) instrument donation program today at the American Association of Clinical Chemistry (AACC) Annual Meeting.

Recipients were Northern Michigan University, Marquette Mich.; University of Nevada, Las Vegas, Nev.; University of Vermont, Burlington, Vt., Texas State University, San Marcos, Texas, Reading Area Community College, Reading, Penn., Southeastern Community College, Whiteville, N.C.; and Western Technical College, LaCrosse, Wis.

Donated instruments included Abbott's AxSYM(R) automated immunoassay analyzer, CELL-DYN(R) hematology instruments and the i-STAT(R) hand-held point-of-care system.

To date, Abbott has donated more than $3 million in instruments, reagents and service to accredited clinical laboratory education programs across the country. Fifty educational programs, impacting 3,000 students in 29 states within the U.S., received state-of-the-art equipment including immunoassay analyzers, hematology systems, and handheld point-of-care diagnostic instruments.

About Labs Are Vital(TM)

"Labs Are Vital(TM)" is a multi-pronged, multi-year global education and awareness initiative designed to highlight the critical role that laboratory professionals play in health care and to address the issues facing laboratories today. The program -- which includes a public awareness campaign, an instrument donation program and a variety of web-based resources for laboratory professionals -- focuses attention on the life-saving work medical laboratory scientists provide in diagnosing disease and improving health outcomes. For more information on the "Labs are Vital(TM)" program, please visit

The AACC Annual Meeting is a global meeting that attracts nearly 20,000 attendees from more than 100 countries.

About Abbott's Diagnostics Businesses

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With more than 65,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnosis from an art to a science through the company's commitment to improving patient care and lowering costs. The history of Abbott is filled with examples of first-of-a-kind diagnostic products and significant technological and research advancements.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
2. Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nations Health Care System
3. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
4. Abbott and Partnership for a Drug-Free America Launch Not In My House to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse
5. Data Show that Abbotts HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
6. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
7. Now Playing: Spike Lee Stands with Earvin Magic Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
8. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
9. Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care
10. Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan
11. Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Post Your Comments:
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: